Patent details

EP3204018 Title: NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES

Basic Information

Publication number:
EP3204018
PCT Application Number:
US2015054011
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158492520
PCT Publication Number:
WO2016057398
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES
French Title of Invention:
UTILISATION NÉOADJUVANTE DE CONJUGUÉS ANTICORPS-MÉDICAMENTS
German Title of Invention:
NEOADJUVANTE VERWENDUNG VON ANTIKÖRPER-WIRKSTOFF-KONJUGATEN
SPC Number:

Dates

Filing date:
05/10/2015
Grant date:
25/08/2021
EP Publication Date:
16/08/2017
PCT Publication Date:
14/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/10/2021
Expiration date:
05/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
Immunomedics, Inc.
Address:
300 American Road, Morris Plains, NJ 07950, United States (US)

Inventor

Name:
GOLDENBERG, David M.
Address:
United States (US)

Priority

Priority Number:
201462060858 P
Priority Date:
07/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/68; A61K 45/06; A61K 31/4745; A61K 31/704; A61K 31/166; A61K 35/00; A61P 35/00; A61P 35/02; A61P 35/04;

Publication

European Patent Bulletin

1

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

2

Issue number:
202139
Publication date:
29/09/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages